N@N

Hythiam to Present at the Roth 23rd Annual OC Growth Stock Conference

^{Published on 2011-03-09 04:25:47 - Market Wire}
 

LOS ANGELES--([ BUSINESS WIRE ])--Hythiam, Inc. (OTCBB:HYTM) announced today that Rick Anderson, President and Chief Operating Officer of Hythiam, will be presenting at the Roth Capital Partners 23^rd Annual OC Growth Stock Conference on Monday, March 14, 2011 at 5:30 p.m. PST. The event will be held March 13-16, 2011 at the Ritz-Carlton in Dana Point, California.

About Hythiam^®

Hythiam, Inc. provides, through Catasys, specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Hythiam does not practice medicine or manufacture, distribute, or sell any medications and has no relationship with any manufacturers or distributors of medications used in the program. For further information, please visit [ www.hythiam.com ].

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history and lack of statistically significant formal research studies, the risk that treatment protocols might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the healthcare industry; and additional risks factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at [ http://www.sec.gov ].